Crumly & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Crumly & Associates's LLY Position: Q3 2026 in Review
Crumly & Associates increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $105K and bringing the position to 882 shares worth $1.02M. The position accounts for 0.18% of the portfolio, ranked #78.
Crumly & Associates first reported a position in LLY in Q4 2020 and has held it in 15 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Crumly & Associates held 882 shares of Eli Lilly worth $1.02M as of Q3 2026.
- Crumly & Associates bought 89 Eli Lilly shares in Q3 2026, an estimated $105K.
- Eli Lilly made up 0.18% of Crumly & Associates's portfolio in Q3 2026, its #78 holding.
- Crumly & Associates first reported a position in Eli Lilly in Q4 2020 and has held it in 15 quarters since.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Crumly & Associates's 13F filing for Q3 2026, filed 7 Oct 2026.